Efficacy and Tolerability of Ramucirumab Plus Erlotinib in Taiwanese Patients with Untreated, Epidermal Growth Factor Receptor-Mutated, Stage IV Non-small Cell Lung Cancer in the RELAY Study
Titel:
Efficacy and Tolerability of Ramucirumab Plus Erlotinib in Taiwanese Patients with Untreated, Epidermal Growth Factor Receptor-Mutated, Stage IV Non-small Cell Lung Cancer in the RELAY Study
Auteur:
Chiu, Chao-Hua Lin, Meng-Chih Wei, Yu-Feng Chang, Gee-Chen Su, Wu-Chou Hsia, Te-Chun Su, Jian Wang, Anne Kuei-Fang Jen, Min-Hua Puri, Tarun Shih, Jin-Yuan